{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:48:20Z","timestamp":1777898900927,"version":"3.51.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5629-x","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T10:03:07Z","timestamp":1560247387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Development and validation of a model that includes two ultrasound parameters and the plasma D-dimer level for predicting malignancy in adnexal masses: an observational study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2376-4663","authenticated-orcid":false,"given":"Maciej","family":"Stukan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Badocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karol","family":"Ratajczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"5629_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1046\/j.0960-7692.2001.00500.x","volume":"18","author":"L Valentin","year":"2001","unstructured":"Valentin L, Hagen B, Tingulstad S, Eik-Nes S. Comparison of 'pattern recognition' and logistic regression models for discrimination between benign and malignant pelvic masses: a prospective cross validation. Ultrasound Obstet Gynecol. 2001;18:357\u201365.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5629_CR2","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.ejca.2011.12.003","volume":"48","author":"T Van Gorp","year":"2012","unstructured":"Van Gorp T, Veldman J, Van Calster B, Cadron I, Leunen K, Amant F, Timmerman D, Vergote I. Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses. Eur J Cancer. 2012;48:1649\u201356.","journal-title":"Eur J Cancer"},{"key":"5629_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejca.2016.01.007","volume":"58","author":"EM Meys","year":"2016","unstructured":"Meys EM, Kaijser J, Kruitwagen RF, Slangen BF, Van Calster B, Aertgeerts B, Verbakel JY, Timmerman D, Van Gorp T. Subjective assessment versus ultrasound models to diagnose ovarian cancer: a systematic review and meta-analysis. Eur J Cancer. 2016;58:17\u201329.","journal-title":"Eur J Cancer"},{"key":"5629_CR4","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/AOG.0b013e318195ad17","volume":"113","author":"P Geomini","year":"2009","unstructured":"Geomini P, Kruitwagen R, Bremer GL, Cnossen J, Mol BW. The accuracy of risk scores in predicting ovarian malignancy: a systematic review. Obstet Gynecol. 2009;113:384\u201394.","journal-title":"Obstet Gynecol"},{"key":"5629_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/humupd\/dmt059","volume":"20","author":"J Kaijser","year":"2014","unstructured":"Kaijser J, Sayasneh A, Van Hoorde K, Ghaem-Maghami S, Bourne T, Timmerman D, Van Calster B. Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis. Hum Reprod Update. 2014;20:449\u201362.","journal-title":"Hum Reprod Update"},{"key":"5629_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.7863\/ultra.34.2.207","volume":"34","author":"M Stukan","year":"2015","unstructured":"Stukan M, Dudziak M, Ratajczak K, Grabowski JP. Usefulness of diagnostic indices comprising clinical, sonographic, and biomarker data for discriminating benign from malignant ovarian masses. J Ultrasound Med. 2015;34:207\u201317.","journal-title":"J Ultrasound Med"},{"key":"5629_CR7","unstructured":"Westwood M. Tests in secondary care to identify people at high risk of ovarian cancer.2017 14\/10\/2017. Available from: \n                    https:\/\/www.nice.org.uk\/guidance\/dg31\/documents\/final-protocol\n                    \n                  ."},{"key":"5629_CR8","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jamcollsurg.2015.01.056","volume":"220","author":"RE Bristow","year":"2015","unstructured":"Bristow RE, Chang J, Ziogas A, Campos B, Chavez LR, Anton-Culver H. Impact of National Cancer Institute Comprehensive Cancer centers on ovarian cancer treatment and survival. J Am Coll Surg. 2015;220:940\u201350.","journal-title":"J Am Coll Surg"},{"key":"5629_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3802\/jgo.2015.26.4.336","volume":"26","author":"SJ Chang","year":"2015","unstructured":"Chang SJ, Bristow RE, Chi DS, Cliby WA. Role of aggressive surgical cytoreduction in advanced ovarian cancer. J Gynecol Oncol. 2015;26:336\u201342.","journal-title":"J Gynecol Oncol"},{"key":"5629_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ygyno.2017.01.029","volume":"145","author":"S Wallace","year":"2017","unstructured":"Wallace S, Kumar A, Mc Gree M, Weaver A, Mariani A, Langstraat C, Dowdy S, Bakkum-Gamez J, Cliby W. Efforts at maximal cytoreduction improve survival in ovarian cancer patients, even when complete gross resection is not feasible. Gynecol Oncol. 2017;145:21\u20136.","journal-title":"Gynecol Oncol"},{"key":"5629_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/jum.14197","volume":"36","author":"P Glanc","year":"2017","unstructured":"Glanc P, Benacerraf B, Bourne T, Brown D, Coleman BG, Crum C, Dodge J, Levine D, Pavlik E, Timmerman D, et al. First international consensus report on adnexal masses: management recommendations. J Ultrasound Med. 2017;36:849\u201363.","journal-title":"J Ultrasound Med"},{"key":"5629_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/uog.10100","volume":"39","author":"AC Testa","year":"2012","unstructured":"Testa AC, Ludovisi M, Mascilini F, Di Legge A, Malaggese M, Fagotti A, Fanfani F, Salerno MG, Ercoli A, Scambia G, et al. Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study. Ultrasound Obstet Gynecol. 2012;39:99\u2013105.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5629_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11912-015-0449-x","volume":"17","author":"D Fischerova","year":"2015","unstructured":"Fischerova D, Cibula D. Ultrasound in gynecological cancer: is it time for re-evaluation of its uses? Curr Oncol Rep. 2015;17:28.","journal-title":"Curr Oncol Rep"},{"key":"5629_CR14","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.ultrasmedbio.2016.05.014","volume":"42","author":"V Weinberger","year":"2016","unstructured":"Weinberger V, Fischerova D, Semeradova I, Slama J, Dundr P, Dusek L, Cibula D, Zikan M. Prospective evaluation of ultrasound accuracy in the detection of pelvic Carcinomatosis in patients with ovarian Cancer. Ultrasound Med Biol. 2016;42:2196\u2013202.","journal-title":"Ultrasound Med Biol"},{"key":"5629_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/uog.15942","volume":"49","author":"D Fischerova","year":"2017","unstructured":"Fischerova D, Zikan M, Semeradova I, Slama J, Kocian R, Dundr P, Nemejcova K, Burgetova A, Dusek L, Cibula D. Ultrasound in preoperative assessment of pelvic and abdominal spread in patients with ovarian cancer: a prospective study. Ultrasound Obstet Gynecol. 2017;49:263\u201374.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5629_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/uog.17363","volume":"50","author":"M Zikan","year":"2017","unstructured":"Zikan M, Fischerova D, Semeradova I, Slama J, Dundr P, Weinberger V, Dusek L, Cibula D. Accuracy of ultrasound in prediction of rectosigmoid infiltration in epithelial ovarian cancer. Ultrasound Obstet Gynecol. 2017;50:533\u20138.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5629_CR17","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1200\/JCO.2009.22.3032","volume":"27","author":"GH Lyman","year":"2009","unstructured":"Lyman GH, Khorana AA. Cancer, clots and consensus: new understanding of an old problem. J Clin Oncol. 2009;27:4821\u20136.","journal-title":"J Clin Oncol"},{"key":"5629_CR18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/IGC.0000000000000415","volume":"25","author":"M Sakurai","year":"2015","unstructured":"Sakurai M, Satoh T, Matsumoto K, Michikami H, Nakamura Y, Nakao S, Ochi H, Onuki M, Minaguchi T, Yoshikawa H. High pretreatment plasma D-dimer levels are associated with poor prognosis in patients with ovarian cancer independently of venous thromboembolism and tumor extension. Int J Gynecol Cancer. 2015;25:593\u20138.","journal-title":"Int J Gynecol Cancer"},{"key":"5629_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/IGC.0000000000000303","volume":"25","author":"YN Man","year":"2015","unstructured":"Man YN, Wang YN, Hao J, Liu X, Liu C, Zhu C, Wu XZ. Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism. Int J Gynecol Cancer. 2015;25:24\u201332.","journal-title":"Int J Gynecol Cancer"},{"key":"5629_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1006\/gyno.1996.0025","volume":"60","author":"A Gadducci","year":"1996","unstructured":"Gadducci A, Baicchi U, Marrai R, Ferdeghini M, Bianchi R, Facchini V. Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses. Gynecol Oncol. 1996;60:197\u2013202.","journal-title":"Gynecol Oncol"},{"key":"5629_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/MBC.0b013e32835e63b7","volume":"24","author":"A Amirkhosravi","year":"2013","unstructured":"Amirkhosravi A, Gt B, Desai H, Rivera-Amaya M, Coll E, Robles-Carrillo L, Faust P, Waters A, Meyer T, Reyes E, et al. Blood clotting activation analysis for preoperative differentiation of benign versus malignant ovarian masses. Blood Coagul Fibrinolysis. 2013;24:510\u20137.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"5629_CR22","first-page":"1395","volume":"96","author":"P Worasethsin","year":"2013","unstructured":"Worasethsin P, Narkwichean A. D-dimer as a tumor marker in pre-operative assessment of adnexal masses. J Med Assoc Thail. 2013;96:1395\u2013400.","journal-title":"J Med Assoc Thail"},{"key":"5629_CR23","unstructured":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer. Version 2.2018.2018 Oct 07, 2018. Available from: \n                    www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf\n                    \n                  ."},{"key":"5629_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejca.2017.06.010","volume":"83","author":"K Michielsen","year":"2017","unstructured":"Michielsen K, Dresen R, Vanslembrouck R, De Keyzer F, Amant F, Mussen E, Leunen K, Berteloot P, Moerman P, Vergote I, et al. Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer. Eur J Cancer. 2017;83:88\u201398.","journal-title":"Eur J Cancer"},{"key":"5629_CR25","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/uog.10054","volume":"38","author":"D Fischerova","year":"2011","unstructured":"Fischerova D. Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors: a review. Ultrasound Obstet Gynecol. 2011;38:246\u201366.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5629_CR26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1046\/j.1469-0705.2000.00287.x","volume":"16","author":"D Timmerman","year":"2000","unstructured":"Timmerman D, Valentin L, Bourne TH, Collins WP, Verrelst H, Vergote I. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the international ovarian tumor analysis (IOTA) group. Ultrasond Obstet Gynecol. 2000;16:500\u20135.","journal-title":"Ultrasond Obstet Gynecol"},{"key":"5629_CR27","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","volume":"97","author":"I Jacobs","year":"1990","unstructured":"Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 1990;97:922\u20139.","journal-title":"Br J Obstet Gynaecol"},{"key":"5629_CR28","doi-asserted-by":"publisher","first-page":"841","DOI":"10.7863\/jum.2001.20.8.841","volume":"20","author":"JL Alcazar","year":"2001","unstructured":"Alcazar JL, Errasti T, Laparte C, Jurado M, Lopez-Garcia G. Assessment of a new logistic model in the preoperative evaluation of adnexal masses. J Ultrasound Med. 2001;20:841\u20138.","journal-title":"J Ultrasound Med"},{"key":"5629_CR29","doi-asserted-by":"publisher","first-page":"g5920","DOI":"10.1136\/bmj.g5920","volume":"349","author":"B Van Calster","year":"2014","unstructured":"Van Calster B, Van Hoorde K, Valentin L, Testa AC, Fischerova D, Van Holsbeke C, Savelli L, Franchi D, Epstein E, Kaijser J, et al. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ. 2014;349:g5920.","journal-title":"BMJ"},{"key":"5629_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/uog.7636","volume":"36","author":"D Timmerman","year":"2010","unstructured":"Timmerman D, Van Calster B, Testa AC, Guerriero S, Fischerova D, Lissoni AA, Van Holsbeke C, Fruscio R, Czekierdowski A, Jurkovic D, et al. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group. Ultrasound Obstet Gynecol. 2010;36:226\u201334.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5629_CR31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/uog.5365","volume":"31","author":"D Timmerman","year":"2008","unstructured":"Timmerman D, Testa AC, Bourne T, Ameye L, Jurkovic D, Van Holsbeke C, Paladini D, Van Calster B, Vergote I, Van Huffel S, et al. Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol. 2008;31:681\u201390.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5629_CR32","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ajog.2016.01.007","volume":"214","author":"D Timmerman","year":"2016","unstructured":"Timmerman D, Van Calster B, Testa A, Savelli L, Fischerova D, Froyman W, Wynants L, Van Holsbeke C, Epstein E, Franchi D, et al. Predicting the risk of malignancy in adnexal masses based on the simple rules from the international ovarian tumor analysis group. Am J Obstet Gynecol. 2016;214:424\u201337.","journal-title":"Am J Obstet Gynecol"},{"key":"5629_CR33","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/00006250-199903000-00028","volume":"93","author":"S Tingulstad","year":"1999","unstructured":"Tingulstad S, Hagen B, Skjeldestad FE, Halvorsen T, Nustad K, Onsrud M. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol. 1999;93:448\u201352.","journal-title":"Obstet Gynecol"},{"key":"5629_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejogrb.2009.02.048","volume":"144","author":"Y Yamamoto","year":"2009","unstructured":"Yamamoto Y, Yamada R, Oguri H, Maeda N, Fukaya T. Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses. Eur J Obstet Gynecol Reprod Biol. 2009;144:163\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"5629_CR35","unstructured":"Tavassoli FA, Devilee P. Pathology and genetics of Tumours of the breast and female genital organs. Lyon: IARCPress; 2003. Available from: \n                    https:\/\/www.iarc.fr\/wp-content\/uploads\/2018\/07\/BB4.pdf"},{"key":"5629_CR36","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1148\/radiol.2015151516","volume":"277","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, Moher D, Rennie D, de Vet HC, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Radiology. 2015;277:826\u201332.","journal-title":"Radiology"},{"key":"5629_CR37","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.","journal-title":"BMJ."},{"key":"5629_CR38","volume-title":"R: a language and environment for statistical computing","author":"RC Team","year":"2017","unstructured":"Team RC. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2017."},{"key":"5629_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-77244-8","volume-title":"Clinical prediction models: a practical approach to development, validation, and updating","author":"E Steyerberg","year":"2009","unstructured":"Steyerberg E. Clinical prediction models: a practical approach to development, validation, and updating. 1st ed. New York: Springer-Verlag; 2009.","edition":"1"},{"key":"5629_CR40","doi-asserted-by":"publisher","unstructured":"Dziak JJ, Coffman DL, Lanza ST, Li R, Jermiin LS. Sensitivity and specificity of information criteria. Brief Bioinform. 2019. \n                    https:\/\/doi.org\/10.1093\/bib\/bbz016\n                    \n                  . \n                    https:\/\/academic.oup.com\/bib\/advance-article-abstract\/doi\/10.1093\/bib\/bbz016\/5380417?redirectedFrom=fulltext\n                    \n                  .","DOI":"10.1093\/bib\/bbz016"},{"key":"5629_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-1534-3","volume-title":"Statistical analysis of microbiome data with R","author":"Y Xia","year":"2018","unstructured":"Xia Y, Sun J, Chen D-G. Statistical analysis of microbiome data with R. Singapore: Springer; 2018."},{"key":"5629_CR42","doi-asserted-by":"publisher","first-page":"b2584","DOI":"10.1136\/bmj.b2584","volume":"339","author":"GS Collins","year":"2009","unstructured":"Collins GS, Altman DG. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. BMJ. 2009;339:b2584.","journal-title":"BMJ."},{"key":"5629_CR43","unstructured":"Harrell Jr F. rms: Regression Modeling Strategies. R package version 5.1\u20132. Department of Biostatistics, Vanderbilt University2018."},{"key":"5629_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0304-4076(88)90077-2","volume":"37","author":"WS Cleveland","year":"1988","unstructured":"Cleveland WS, Devlin SJ, Grosse E. Regression by local fitting: methods, properties, and computational algorithms. J Econ. 1988;37:87\u2013114.","journal-title":"J Econ"},{"key":"5629_CR45","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and cox regression. Am J Epidemiol. 2007;165:710\u20138.","journal-title":"Am J Epidemiol"},{"key":"5629_CR46","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/uog.13437","volume":"44","author":"N Nunes","year":"2014","unstructured":"Nunes N, Ambler G, Foo X, Naftalin J, Widschwendter M, Jurkovic D. Use of IOTA simple rules for diagnosis of ovarian cancer: meta-analysis. Ultrasound Obstet Gynecol. 2014;44:503\u201314.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5629_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0090-8258(89)90031-0","volume":"35","author":"S Granberg","year":"1989","unstructured":"Granberg S, Wikland M, Jansson I. Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: criteria to be used for ultrasound evaluation. Gynecol Oncol. 1989;35:139\u201344.","journal-title":"Gynecol Oncol"},{"key":"5629_CR48","first-page":"70","volume":"78","author":"AM Sassone","year":"1991","unstructured":"Sassone AM, Timor-Tritsch IE, Artner A, Westhoff C, Warren WB. Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol. 1991;78:70\u20136.","journal-title":"Obstet Gynecol"},{"key":"5629_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1006\/gyno.1993.1238","volume":"51","author":"PD DePriest","year":"1993","unstructured":"DePriest PD, Shenson D, Fried A, Hunter JE, Andrews SJ, Gallion HH, Pavlik EJ, Kryscio RJ, van Nagell JR Jr. A morphology index based on sonographic findings in ovarian cancer. Gynecol Oncol. 1993;51:7\u201311.","journal-title":"Gynecol Oncol"},{"key":"5629_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0002-9378(94)70388-4","volume":"170","author":"JP Lerner","year":"1994","unstructured":"Lerner JP, Timor-Tritsch IE, Federman A, Abramovich G. Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring system. Am J Obstet Gynecol. 1994;170:81\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"5629_CR51","first-page":"254","volume":"81","author":"A Smolen","year":"2010","unstructured":"Smolen A, Stachowicz N, Czekierowski A, Kotarski J. The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors. Ginekol Pol. 2010;81:254\u201361.","journal-title":"Ginekol Pol"},{"key":"5629_CR52","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1046\/j.1469-0705.2002.00776.x","volume":"20","author":"N Berlanda","year":"2002","unstructured":"Berlanda N, Ferrari MM, Mezzopane R, Boero V, Grijuela B, Ferrazzi E, Pardi G. Impact of a multiparameter, ultrasound-based triage on surgical management of adnexal masses. Ultrasound Obstet Gynecol. 2002;20:181\u20135.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5629_CR53","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0090-8258(03)00414-1","volume":"91","author":"FR Ueland","year":"2003","unstructured":"Ueland FR, DePriest PD, Pavlik EJ, Kryscio RJ, van Nagell JR Jr. Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography. Gynecol Oncol. 2003;91:46\u201350.","journal-title":"Gynecol Oncol"},{"key":"5629_CR54","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1161\/ATVBAHA.108.182188","volume":"29","author":"I Pabinger","year":"2009","unstructured":"Pabinger I, Ay C. Biomarkers and venous thromboembolism. Arterioscler Thromb Vasc Biol. 2009;29:332\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5629_CR55","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3324\/haematol.2011.054718","volume":"97","author":"C Ay","year":"2012","unstructured":"Ay C, Dunkler D, Pirker R, Thaler J, Quehenberger P, Wagner O, Zielinski C, Pabinger I. High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica. 2012;97:1158\u201364.","journal-title":"Haematologica"},{"key":"5629_CR56","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/sj.bjc.6603989","volume":"97","author":"T Satoh","year":"2007","unstructured":"Satoh T, Oki A, Uno K, Sakurai M, Ochi H, Okada S, Minami R, Matsumoto K, Tanaka YO, Tsunoda H, et al. High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer. 2007;97:1053\u20137.","journal-title":"Br J Cancer"},{"key":"5629_CR57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3802\/jgo.2012.23.2.98","volume":"23","author":"R Kawaguchi","year":"2012","unstructured":"Kawaguchi R, Furukawa N, Kobayashi H. Cut-off value of D-dimer for prediction of deep venous thrombosis before treatment in ovarian cancer. J Gynecol Oncol. 2012;23:98\u2013102.","journal-title":"J Gynecol Oncol"},{"key":"5629_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13048-018-0382-3","volume":"11","author":"YY Qin","year":"2018","unstructured":"Qin YY, Wu YY, Xian XY, Qin JQ, Lai ZF, Liao L, Lin FQ. Single and combined use of red cell distribution width, mean platelet volume, and cancer antigen 125 for differential diagnosis of ovarian cancer and benign ovarian tumors. J Ovarian Res. 2018;11:10.","journal-title":"J Ovarian Res"},{"issue":"Suppl 6","key":"5629_CR59","doi-asserted-by":"publisher","first-page":"vi24","DOI":"10.1093\/annonc\/mdt333","volume":"24","author":"JA Ledermann","year":"2013","unstructured":"Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C, Group EGW. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi24\u201332.","journal-title":"Ann Oncol"},{"key":"5629_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/jco.2009.27.18_suppl.1","volume":"27","author":"GJ Rustin","year":"2009","unstructured":"Rustin GJ, MEvd B. A randomized trial in ovarian cancer (OC) of early treatment of relapse based on CA125 level alone versus delayed treatment based on conventional clinical indicators (MRC OV05\/EORTC 55955 trials). J Clin Oncol. 2009;27:1.","journal-title":"J Clin Oncol"},{"key":"5629_CR61","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1200\/JCO.2006.09.5943","volume":"25","author":"D Timmerman","year":"2007","unstructured":"Timmerman D, Van Calster B, Jurkovic D, Valentin L, Testa AC, Bernard JP, Van Holsbeke C, Van Huffel S, Vergote I, Bourne T. Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors. J Clin Oncol. 2007;25:4194\u2013200.","journal-title":"J Clin Oncol"},{"key":"5629_CR62","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1158\/1055-9965.EPI-11-0422","volume":"20","author":"B Van Calster","year":"2011","unstructured":"Van Calster B, Valentin L, Van Holsbeke C, Zhang J, Jurkovic D, Lissoni AA, Testa AC, Czekierdowski A, Fischerova D, Domali E, et al. A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational study. Cancer Epidemiol Biomark Prev. 2011;20:2420\u20138.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"5629_CR63","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/uog.6415","volume":"34","author":"L Valentin","year":"2009","unstructured":"Valentin L, Jurkovic D, Van Calster B, Testa A, Van Holsbeke C, Bourne T, Vergote I, Van Huffel S, Timmerman D. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses. Ultrasound Obstet Gynecol. 2009;34:345\u201354.","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5629-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5629-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5629-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T23:13:43Z","timestamp":1591744423000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5629-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5629"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5629-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"assertion":[{"value":"17 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the local Ethics Committee at Medical Council in Gdansk, Poland (KB \u2013 36\/17). Informed consent was obtained from all participants. It was a verbal consent, because all tests (imaging and laboratory) were performed as a routine clinical evaluations, according to institutional guidelines. There were no additional tests for the purpose of the study, performed on participants. All model\u2019s calculations were performed after the study concluded; thus, the models played no role in the decision-making process. The above mentioned ethics committee approved this procedure.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"564"}}